about
Proteus mirabilis and Urinary Tract Infections.From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Endoscopic and Pathologic Characterization of Papillary Architecture in Struvite Stone Formers.Ureolytic Biomineralization Reduces Proteus mirabilis Biofilm Susceptibility to Ciprofloxacin.Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.Epidemiology of pediatric urolithiasisSecondarily infected nonstruvite urolithiasis: a prospective evaluation.Bis(aminomethyl)phosphinic Acid, a Highly Promising Scaffold for the Development of Bacterial Urease Inhibitors.Approach to the Adult Kidney Stone FormerKidney stones in children and teenagers in the central coast region of TunisiaComplicated urinary tract infection is associated with uroepithelial expression of proinflammatory protein S100A8.History, epidemiology and regional diversities of urolithiasis.The general practitioner and nephrolithiasis.History of kidney stones and risk of chronic kidney disease: a meta-analysis.Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review.Renal struvite stones--pathogenesis, microbiology, and management strategies.From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation.Do stones still kill? An analysis of death from stone disease 1999-2013 in England and Wales.Pseudotuberculous Granulomatous Pyelitis.Unique surface and internal structure of struvite crystals formed by Proteus mirabilis.Effect of Curcumin Against Proteus mirabilis During Crystallization of Struvite from Artificial Urine.Biomimetic synthesis of struvite with biogenic morphology and implication for pathological biomineralization.Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract.Stability of the infection marker struvite in urinary stone samples.Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous subcutaneous magnesium infusion.Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up.[Infection-induced urinary stones].Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence.Evaluating factors that dictate struvite stone composition: A multi-institutional clinical experience from the EDGE Research Consortium.Evaluation of in vitro and in vivo anti-urolithiatic activity of silver nanoparticles containing aqueous leaf extract of Tragia involucrata.Bacteria can promote calcium oxalate crystal growth and aggregation.Management of staghorn renal stones.Risk factors for urinary tract infection in patients with urolithiasis-primary report of a single center cohort.Morphological and micro-tomographic study on evolution of struvite in synthetic urine infected with bacteria and investigation of its pathological biomineralization
P2860
Q26779002-69B036DE-65EC-459E-BD64-EEDDDAC55D8DQ30424697-B74D469B-EF5F-4FF0-A03D-E509ADFC7F39Q30736232-B7C6CB83-6605-43BD-BBBD-23E1D98E5B1BQ30755612-AC816E9E-85CD-46B6-ACEE-F1792D16638EQ34265048-E2EBD3A6-ABFF-4B51-9527-2006D69A28DAQ34553714-A0E12184-AC91-47D5-8A70-186B5213F242Q34637614-7D05C21E-A3CF-4421-AA14-66947805D20AQ35086742-39F40375-A61C-4001-A5FA-FC924B3371A0Q35990584-B963E4C7-2DD9-4AAC-BEEE-1417FF68123CQ36586791-56964959-825B-4054-87FA-AE3A415D5E8EQ37355901-1DAEF323-D0B1-4F72-8A71-0781AFCFB93AQ37424602-0369373F-4959-4FC5-89DF-0C66218D8AE2Q37430351-C96EA1F4-4FC5-4D18-92B3-1B5E478C5DE2Q37608002-E936CF54-E3A6-4C36-9391-C5257D03DCA1Q37860345-4DEF5EC4-72E2-44E0-B9DA-723F79DA8D4FQ38211116-4B5A877A-4AE4-482E-8564-1E0D44055519Q39054200-6864513E-EA0E-48DB-B381-E5331CD03634Q39069615-D610D6CB-D6A2-45BD-80EA-FE2223A7A5D8Q40109662-75E0CDEE-A6BC-412E-9B79-78D9A15DEDE7Q40605642-8BACEC60-1E39-469E-AF4C-D5A0803DB3B1Q41256018-BA907503-3165-4E40-8AA2-560484ECD546Q41790861-B2AFDF54-119F-418C-AA21-E584EF8E0C26Q41851239-C6F07BBD-0869-4793-AD52-2DAAA8BE85FEQ41991551-1C88B34C-1857-4AEE-A4AF-05ECF53419E0Q42175715-955414CD-6CBA-4023-B9EC-96030A499906Q43734970-1753952E-83A9-4F8C-8C22-BA23E3B83BF5Q43931110-60224FD8-D5BC-4D74-BFE1-ECCFB614C780Q44307277-B8697FA3-354F-4534-8ADF-19488E654F75Q44736954-0B7EB49B-774E-45B0-8638-8DB5FB665729Q50106359-DBC938D5-8186-40D8-90A0-9DAB79D133C8Q50206882-A17F1283-CDC7-49DA-8283-BF1D4B1060F6Q50496581-577A4994-BF0E-495C-A3CB-945DE7D02E2CQ52586835-44E47029-5260-4615-BFBE-62CE27B90D53Q54203962-658689E3-3D65-4763-A66A-5ADB6ACAD964Q58783353-F847E52D-B90D-4A0E-B3EE-64CD473F1144
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Urinary infection stones.
@ast
Urinary infection stones.
@en
Urinary infection stones.
@nl
type
label
Urinary infection stones.
@ast
Urinary infection stones.
@en
Urinary infection stones.
@nl
prefLabel
Urinary infection stones.
@ast
Urinary infection stones.
@en
Urinary infection stones.
@nl
P2093
P1476
Urinary infection stones.
@en
P2093
P304
P356
10.1016/S0924-8579(02)00088-2
P577
2002-06-01T00:00:00Z